Net profit of JFL Life Sciences rose 1975.00% to Rs 1.66 crore in the quarter ended March 2026 as against Rs 0.08 crore during the previous quarter ended March 2025. Sales rose 437.51% to Rs 63.05 crore in the quarter ended March 2026 as against Rs 11.73 crore during the previous quarter ended March 2025.
For the full year,net profit rose 53.85% to Rs 6.40 crore in the year ended March 2026 as against Rs 4.16 crore during the previous year ended March 2025. Sales rose 60.14% to Rs 131.38 crore in the year ended March 2026 as against Rs 82.04 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 63.05 | 11.73 | 438 | 131.38 | 82.04 | 60 |
| OPM % | 5.57 | 11.68 | - | 8.92 | 10.00 | - |
| PBDT | 2.52 | 1.04 | 142 | 9.68 | 7.13 | 36 |
| PBT | 2.25 | 0.68 | 231 | 8.60 | 6.14 | 40 |
| NP | 1.66 | 0.08 | 1975 | 6.40 | 4.16 | 54 |
Powered by Capital Market - Live News